176 related articles for article (PubMed ID: 32445050)
1. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK
Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050
[TBL] [Abstract][Full Text] [Related]
2. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J
PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680
[TBL] [Abstract][Full Text] [Related]
3. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.
Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X
Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640
[TBL] [Abstract][Full Text] [Related]
4. Aspartate β-hydroxylase (ASPH) Accelerates Intrahepatic Cholangiocarcinoma Metastasis
Zou Y; Lin J; Liu J; Zhang F; Yang T; Gong J; Jiang T; Zuo J; Song R; Shen H; Shen F; Li J
Curr Protein Pept Sci; 2023; 24(5):436-446. PubMed ID: 37132101
[TBL] [Abstract][Full Text] [Related]
5. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
6. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.
Aihara A; Huang CK; Olsen MJ; Lin Q; Chung W; Tang Q; Dong X; Wands JR
Hepatology; 2014 Oct; 60(4):1302-13. PubMed ID: 24954865
[TBL] [Abstract][Full Text] [Related]
7. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
Huang CK; Iwagami Y; Zou J; Casulli S; Lu S; Nagaoka K; Ji C; Ogawa K; Cao KY; Gao JS; Carlson RI; Wands JR
Cancer Lett; 2018 Aug; 429():1-10. PubMed ID: 29733964
[TBL] [Abstract][Full Text] [Related]
8. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review).
Zheng W; Wang X; Hu J; Bai B; Zhu H
Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.
Zou Q; Hou Y; Wang H; Wang K; Xing X; Xia Y; Wan X; Li J; Jiao B; Liu J; Huang A; Wu D; Xiang H; Pawlik TM; Wang H; Lau WY; Wang Y; Shen F
EBioMedicine; 2018 May; 31():287-298. PubMed ID: 29764768
[TBL] [Abstract][Full Text] [Related]
10. Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models.
Mukherjee P; Zhou X; Galli S; Davidson B; Zhang L; Ahn J; Aljuhani R; Benicky J; Ailles L; Pomin VH; Olsen M; Goldman R
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732216
[TBL] [Abstract][Full Text] [Related]
11. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk.
Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N
Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968
[TBL] [Abstract][Full Text] [Related]
12. Aspartate β-hydroxylase as a target for cancer therapy.
Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R
J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566
[TBL] [Abstract][Full Text] [Related]
13. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
[TBL] [Abstract][Full Text] [Related]
14. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
15. Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase.
Nagaoka K; Bai X; Liu D; Cao K; Mulla J; Ji C; Chen H; Nisar MA; Bay A; Mueller W; Hildebrand G; Gao JS; Lu S; Setoyama H; Tanaka Y; Wands JR; Huang CK
Cancer Lett; 2024 Jan; 580():216493. PubMed ID: 37977350
[TBL] [Abstract][Full Text] [Related]
16. Circ_ASPH promotes cholangiocarcinoma growth and metastasis through the miR-581/ATP-binding cassette transporter G1 signaling pathway.
Xu Y; Kang P; Leng K; Yao Y; Liao G; Han Y; Shi G; Zhong X; Cui Y
Cancer Commun (Lond); 2020 Oct; 40(10):545-550. PubMed ID: 32735059
[No Abstract] [Full Text] [Related]
17. Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.
Noda T; Shimoda M; Ortiz V; Sirica AE; Wands JR
Hepatology; 2012 Jan; 55(1):86-97. PubMed ID: 21898484
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.
Nagaoka K; Bai X; Ogawa K; Dong X; Zhang S; Zhou Y; Carlson RI; Jiang ZG; Fuller S; Lebowitz MS; Ghanbari H; Wands JR
Cancer Lett; 2019 May; 449():87-98. PubMed ID: 30768955
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J
J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update.
Hou G; Xu B; Bi Y; Wu C; Ru B; Sun B; Bai X
Bosn J Basic Med Sci; 2018 Nov; 18(4):297-304. PubMed ID: 30179586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]